Deadline: 13 October 2016
The European and Developing Countries Clinical Trials Partnership (EDCTP) is currently inviting applications for Vaccines for Poverty-Related Diseases program with an aim to support large-scale collaborative projects which include one or more clinical trials aiming to accelerate the clinical development of new vaccines (preventive or therapeutic) against one of the PRDs.
Vaccines have contributed enormously to the successful control and elimination of many diseases. To date, few vaccines have been developed for controlling poverty-related diseases (PRDs). In recent years, several candidate vaccines against PRDs have entered clinical development and there is an urgent need to fast track their development. The aim is to increase the number of promising vaccines targeted for use especially in Africa.
- Call budget is € 70M
- Maximum funding is € 15M
- Consortia comprising a minimum of three independent legal entities are eligible to apply.
- Two of the legal entities must be established in two different European Participating States(2) of the EDCTP Association and one of the legal entities must be established in a sub-Saharan African country(3).
- All three legal entities shall be independent of each other.
- ‘Sole participants’ formed by several legal entities (e.g. European Research Infrastructure Consortia, European Groupings of Territorial Cooperation, central purchasing bodies) are eligible if the above-mentioned minimum conditions are satisfied by the legal entities forming together the sole participant.
How to Apply
Applications must be submitted online via the given website.
Sub-Saharan African Countries: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of Congo, Republic of Congo, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, São Tomé & Príncipe, Senegal, Seychelles, Sierra Leone, Somalia, South Sudan, South Africa, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia and Zimbabwe.
For more information, please visit Vaccines for Poverty-Related Diseases.